Cancer-killing pill that 'annihilates' tumors now being tested on humans
Scientists at a major US hospital have developed a ‘cancer-killing pill’ that appears to ‘annihilate’ solid tumors through targeted chemotherapy.
Scientists at a major US hospital have developed a ‘cancer-killing pill’ that appears to ‘annihilate’ solid tumors through targeted chemotherapy.
Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage them and is an important part of clincal trials.